Organon & Co | OGN - DEBITO





DEBITO Cambiamento Data
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Celltrion KRW 161.31B 9.78B 2025-12
Cspc Pharmaceutical CNY 495M 12.33M 2025-06
Deva Holding AS TRY 5.3B 871.93M 2023-09
Dianthus Therapeutics USD 1.28M 45K 2025-09
Divis Laboratories Ltd INR 40M 40M 2025-03
Gilead Sciences USD 24.94B 5M 2025-12
Glaxosmithkline GBP 17.75B 396M 2025-09
Kangmei Pharma CNY 131.64M 90.18M 2025-06
Knight Therapeutics CAD 77.91M 28.33M 2025-12
Laboratorios Farma EUR 129.3M 14.89M 2025-06
Malin Corporation EUR 100K 0 2023-12
Medical Developments International AUD 1.99M 152K 2025-06
Merck USD 49.34B 7.97B 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-12
Novartis USD 32.02B 615M 2025-09
Organon & Co USD 8.64B 184M 2025-12
Ovoca Bio EUR 0 0 2021-06
Pharma Mar EUR 47.54M 1.88M 2026-03
Qiagen NV USD 1.81B 314.82M 2025-12
Sartorius EUR 4.28B 372.9M 2025-12
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Tilray USD 640.95M 35.17M 2022-06